DDInter948 DDInter1
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Abacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. Chemically, it is a synthetic carbocyclic nucleoside and is the enantiomer with 1S, 4R absolute configuration on the cyclopentene ring. In vivo, abacavir sulfate dissociates to its free base, abacavir.
Abacavir {u} (Compound) resembles {v} (Compound) Nelarabine
Abacavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cladribine
Abacavir {u} (Compound) treats {v} (Disease) acquired immunodeficiency syndrome
Abacavir {u} (Compound) binds {v} (Gene) ADH6
Abacavir {u} (Compound) is included by {v} (Pharmacologic Class) Nucleoside Reverse Transcriptase Inhibitors
Abacavir {u} (Compound) causes {v} (Side Effect) Connective tissue disorder
Abacavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cabozantinib
Abacavir {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Abacavir (Compound) resembles Nelarabine (Compound)
Abacavir may cause a moderate interaction that could exacerbate diseases when taken with Cladribine
Abacavir (Compound) treats acquired immunodeficiency syndrome (Disease)
Abacavir (Compound) binds ADH6 (Gene)
Abacavir (Compound) is included by Nucleoside Reverse Transcriptase Inhibitors (Pharmacologic Class)
Abacavir (Compound) causes Connective tissue disorder (Side Effect)
Abacavir may cause a moderate interaction that could exacerbate diseases when taken with Cabozantinib
Abacavir may lead to a major life threatening interaction when taken with Teriflunomide